Overview
Overview of available data to assess the benefits of HBOT to DFU patients
Description
10 year retrospective registry to measure outcomes regarding major amputations, mortality, hospital admissions in patients with a diabetic foot ulcer with peripheral ischaemia. Two groups will be compared: complementary HBOT and a control group.
Eligibility
Inclusion Criteria:
- Diabetes mellitus
- Meggitt-Wagner classification grade 2-4, existing > 4 weeks
- Complete 1 year follow-up
Exclusion Criteria:
- Chronic Obstructive Pulmonary Disease (COPD) GOLD IV
- Treatment with chemotherapy, immunosuppressive drugs or systemic corticosteroids within the last 3 months
- Metastasized malignancy
- Left ventricular ejection fraction (EF) <20% or external pacemaker
- Recent thoracic or middle ear surgery
- Severe epilepsy
- Uncontrollable high fever
- Pregnancy